Skip to main content
Caplight Logo









Longly Capital

Longly Capital

Overview

Longly Capital is a healthcare-focused investment firm that provides financial investment, strategy consulting, and clinical resources to support the growth of biotech and healthcare companies.

Portfolio Companies

1

Investments

Longly Capital investments
CompanyDateStageLead
Hangzhou Bigfish Bio-tech Co., Ltd.May 2019Pre SeedCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is Longly Capital based?

Longly Capital is headquartered in Shanghai, China.

When was Longly Capital founded?

Founding year information for Longly Capital is not publicly available.

How many portfolio companies does Longly Capital have?

Longly Capital has 1 portfolio company in Caplight's dataset.

What are some companies in Longly Capital's portfolio?

Portfolio companies visible on Caplight include Hangzhou Bigfish Bio-tech Co., Ltd..

What was Longly Capital's most recent investment shown here?

Longly Capital's most recent investment in this portfolio sample was in Hangzhou Bigfish Bio-tech Co., Ltd. in 2019.

What sectors does Longly Capital focus on?

Longly Capital focuses on Healthcare & Life Sciences.

What company stages does Longly Capital focus on?

Longly Capital typically invests at the Early stage.

Firmographic Details

HeadquartersShanghai
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?